1. Home
  2. RENX vs ADVB Comparison

RENX vs ADVB Comparison

Compare RENX & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenX Enterprises Corp. Common Stock

RENX

RenX Enterprises Corp. Common Stock

N/A

Current Price

$2.05

Market Cap

6.0M

Sector

N/A

ML Signal

N/A

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$7.19

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RENX
ADVB
Founded
2021
2014
Country
United States
United States
Employees
38
31
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
6.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RENX
ADVB
Price
$2.05
$7.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
527.8K
314.9K
Earning Date
05-22-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.26
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$0.19
52 Week High
$3.48
$7.59

Technical Indicators

Market Signals
Indicator
RENX
ADVB
Relative Strength Index (RSI) 46.85 67.18
Support Level $0.12 $0.33
Resistance Level $3.15 $7.59
Average True Range (ATR) 0.23 0.80
MACD -0.11 0.04
Stochastic Oscillator 28.95 89.66

Price Performance

Historical Comparison
RENX
ADVB

About RENX RenX Enterprises Corp. Common Stock

RenX Enterprises Corp is engaged in real property development using purpose-built, prefabricated modules constructed from both wood and steel. The Company's operations mainly focused on the acquisition, entitlement, and development of residential properties in high-growth markets across the United States. These efforts included the direct acquisition of land, strategic investments in real estate entities, and joint venture partnerships targeting green, single-family, and multifamily housing projects. The company operates into four segments as of December 31, 2025: real estate development, technology, compost sales, and logistics.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: